Multimorbidity and SARS-CoV-2 Infection in UK Biobank
journal contribution
posted on 2020-06-03, 10:35authored byY Chudasama, C Gillies, K Appiah, F Zaccardi, C Razieh, M Davies, T Yates, K Khunti
Evidence to date has focused on assessing the individual prevalence and impact of comorbidities in patients with coronavirus disease (COVID-19).[1]We aimed to investigate the pattern of the most prevalent combinations of multimorbidity(i.e. presence of two or more pre-existing chronic diseases) in those infected with SARS-CoV-2.
Funding
The National Institute for Health Research (NIHR) Applied Research Collaboration East Midlands (ARC-EM). Data was analysed using UK Biobank application number 36371.
History
Citation
Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2020) In Press
Version
AM (Accepted Manuscript)
Published in
Diabetes and Metabolic Syndrome: Clinical Research and Reviews